Jun 2010
ProImmune launches DC T Cell Proliferation Assay for immunogenicity assessment of whole proteins
Dec 2009
ProImmune launches novel class-leading CFSE T cell proliferation assays for assessing drug immunogenicity risk
Mar 2009
ProImmune accelerates development of therapeutics with REVEAL™ B Cell Epitope Discovery System
Nov 2008
ProImmune launches REVEAL™ Immunogenicity System for development and testing of biologics with reduced immunogenicity
Sep 2007
ProImmune launches new MHC-peptide binding assay for class II HLA alleles
Merck KGaA collaborates with ProImmune Limited for use of ProImmune's REVEAL & ProVE® Rapid Epitope Discovery System in Merck Serono's immunotherapy programme
Aug 2007
ProImmune joins international consortium to develop therapeutic vaccines for non-Hodgkin's lymphoma (NHL)
Feb 2006
New technology for accelerating development of vaccines against H5N1 Flu enters pilot study at ProImmune
Dec 2005
ProImmune launches biotin-labeled Pentamers and Pro5® Biotag to expand Pentamer applications
Sep 2005
ProImmune participates in international research programme to improve transplant tolerance
Jun 2005
Oxford University researchers and ProImmune work together to accelerate HIV vaccine research
Apr 2005
ProImmune launches ProVE® MHC Pentamer Libraries making Pentamers affordable for epitope analysis
Mar 2005
ProImmune moves its corporate headquarters to the Oxford Science Park
Jan 2005
ProImmune Expands its Offering of Monoclonal Antibodies for the Study of T Cell Immunity
Nov 2004
ProImmune Ltd. to distribute PEPscreen®: Custom Peptide Libraries in alliance with Sigma-Genosys
Apr 2004
ProImmune Participates in International Research Programme to Drive Forward Cancer Research
Sep 2010
Unbiased, professional CMI Assays
Aug 2010
Pro5® Pentamer Case Study: Pentamers used in study to advance research into cancer immunotherapy
20% Off HLA Tissue Typing
Jul 2010
Identify Biomarkers for Vaccine Development
The ProImmune Quiz - July 2010
Preclinical ELISPOT Service
Progress Vaccine and Immunotherapy Development Faster
Register for our webcast on Wednesday 23rd June, 'The REVEAL™ Immunogenicity System'
Manage drug immunogenicity before going to the clinic
May 2010
Download your copy of the ProImmune May 2010 Newsletter
Outsource ICS and ELISpot Assays to ProImmune
Customer's Success Staining Rhesus Macaque PBMCs with ProImmune's Human CD1d Tetramer
Apr 2010
Predict Immunogenicity at the Pre-clinical Stage
Let Us Manage Your Cell Mediated Immunity Assays
REVEAL™ Complete Rate Assays for Analytical Characterization of MHC-peptide Binding
Mar 2010
Outsource B Cell Epitope Discovery to the Experts
Detect NKT Cells with Human CD1d Tetramers
Feb 2010
Webcast invitation: T Cell Epitope Discovery Tutorial
ELISPOT Service Integral to Success of Cancer Gene Therapy Study
Jan 2010
Outsource HLA Tissue Typing to the Experts
When accuracy and throughput are paramount, outsource your T cell assays to ProImmune
REVEAL™ MHC-Peptide Binding Assays Now Available for Alleles H-2 IAb and IAd
Nov 2009
Human CD1d Tetramers for NKT Cell Staining
Let us do your HLA Tissue Typing
Breakthrough for Mouse Class II Epitope Discovery (November Newsletter PDF)
Oct 2009
Unravel hidden information about your target
Trust your cellular assays to the immunology experts
